Compare Allstate Corp (ALL) vs Ascendis Pharma A/S (ASND) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Allstate Corp vs Ascendis Pharma A/S — how do they compare? Allstate Corp trades at $262 (market cap $66.31B), while Ascendis Pharma A/S trades at $254.5 (market cap $16.67B). The key difference: Allstate Corp is far larger — about 4× Ascendis Pharma A/S's market cap, and Allstate Corp pays a 1.65% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ALL | ASND | |
|---|---|---|
Market Cap | $66.31B | $16.67B |
Sector | Financials | Health |
52-Week High | $275.11 | $277.18 |
52-Week Low | $190.00 | $189.74 |
Enterprise Value | $74.96B | $17.04B |
Dividend Yield | 1.65% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Allstate Corp
On the basis of premium sales, Allstate is one of the largest U.S. property and casualty insurers. Personal auto represents the largest percentage of revenue, but the company offers homeowners insurance and other insurance products. Allstate products are sold in North America primarily by about 10,000 agencies.
Read more on ALL →About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →
